Renegade.bio develops next generation diagnostic assays for early disease detection and prevention, personalized medicine, drug development, and health monitoring using PCR, NGS, LCMS, and other cutting-edge technologies. We are your committed resource for COVID-testing, and diagnostics across a multitude of disease spaces.
We perform the SalivaDirect™ and renegadeXP™ diagnostic testing methods at our CLIA-certified laboratory in Oakland. Both are qRT-PCR tests (also called PCR or qPCR), the gold standard for diagnostic testing.
Renegade.bio provides a fully comprehensive end-to-end solution for SARS-CoV-2 testing. We’re working day and night with a singular goal to make COVID-19 testing accessible to everyone, regardless of income.
Improving access to diagnostics is crucial for receiving quality healthcare. We develop novel diagnostics, as well as partner with biotech companies, to help create and validate diagnostics—addressing some of healthcare’s biggest challenges across fertility, sexual health, and cardiovascular disease.
By utilizing innovative biotechnology, we hope to better improve the lives of underserved populations. Find out more about our key technology areas in PCR, NGS, LCMS.
If you are a biotech company or research institution looking for a lab partner, find out more here.